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Abstract
Physical activity and molecular ageing presumably interact to precipitate musculoskeletal decline in humans with age.
Herein, we have delineated molecular networks for these two major components of sarcopenic risk using multiple
independent clinical cohorts. We generated genome-wide transcript profiles from individuals (n = 44) who then undertook
20 weeks of supervised resistance-exercise training (RET). Expectedly, our subjects exhibited a marked range of hypertrophic
responses (3% to +28%), and when applying Ingenuity Pathway Analysis (IPA) up-stream analysis to ,580 genes that co-
varied with gain in lean mass, we identified rapamycin (mTOR) signaling associating with growth (P= 1.4610230).
Paradoxically, those displaying most hypertrophy exhibited an inhibited mTOR activation signature, including the striking
down-regulation of 70 rRNAs. Differential analysis found networks mimicking developmental processes (activated all-trans-
retinoic acid (ATRA, Z-score = 4.5; P= 6610213) and inhibited aryl-hydrocarbon receptor signaling (AhR, Z-score =22.3;
P= 361027)) with RET. Intriguingly, as ATRA and AhR gene-sets were also a feature of endurance exercise training (EET), they
appear to represent ‘‘generic’’ physical activity responsive gene-networks. For age, we found that differential gene-
expression methods do not produce consistent molecular differences between young versus old individuals. Instead,
utilizing two independent cohorts (n = 45 and n= 52), with a continuum of subject ages (18–78 y), the first reproducible set
of age-related transcripts in human muscle was identified. This analysis identified ,500 genes highly enriched in post-
transcriptional processes (P= 161026) and with negligible links to the aforementioned generic exercise regulated gene-sets
and some overlap with ribosomal genes. The RNA signatures from multiple compounds all targeting serotonin, DNA
topoisomerase antagonism, and RXR activation were significantly related to the muscle age-related genes. Finally, a number
of specific chromosomal loci, including 1q12 and 13q21, contributed by more than chance to the age-related gene list
(P = 0.01–0.005), implying possible epigenetic events. We conclude that human muscle age-related molecular processes
appear distinct from the processes regulated by those of physical activity.
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Introduction
Discovery of the biological determinants of muscle mass and
functional molecular phenotypes has substantial bearing on the
fields of human performance (e.g. hypertrophy, strength or
endurance adaptations [1,2]) and human health (countering
muscle atrophy and deconditioning occurring in older age or
with conditions such as cancer cachexia [3,4], respiratory disease
or medically enforced immobilization (e.g. hospitalized bed-rest,
cast-immobilization [5,6])). Resistance exercise (RE) training
(RET) is an effective intervention to increase muscle mass in
many, but not all people, and thus provides an excellent
opportunity to study gene-network regulation during muscle
hypertrophy and the proposed relationship to muscle aging. Many
exogenous factors may influence RET-induced hypertrophy
including manipulation of exercise volume [7], intensity [8] and
adequate macronutrient availability [9] all of which interact with
an individual’s genotype to determine muscle growth. Establishing
the molecular diagnostics that enable a personalized approach to
tackle ageing has great appeal.
To date, the molecular regulation of muscle hypertrophy has
mostly focused on aspects of post-genomic signaling, with early
work concluding that canonical insulin-like growth factor (IGF-1)
signals control muscle hypertrophy though a phosphatidyl-inositol-
3 kinase/protein kinase B/mechanistic target of rapamycin
(PI3K/AKT/mTORc1) pathway [10], abbreviated to mTOR.
This protein complex can control cell growth through two
mechanisms; firstly, mTORC1 regulates efficiency of translation
PLOS Genetics | www.plosgenetics.org 1 March 2013 | Volume 9 | Issue 3 | e1003389
through inducing phosphorylation of its substrates, ribosomal
protein S6 kinase (S6K1) and 4E binding protein 1 (4EBP1) and,
secondly, mTORC1 increases translational capacity through
regulating ribosomal RNA (rRNA) production within the nucle-
olus [11]. There are however conflicting data regarding the
importance of mTOR regulation (protein phosphorylation or
target gene mRNA responses) or its up-stream regulators, and
acute anabolic or chronic growth responses to resistance exercise
[12–17] reported from the same laboratories, indicating that
important biological rather than methodological issues remain to
be identified.
More recent evidence indicates that the mechanisms regulating
muscle hypertrophy go beyond the canonical IGF-1/PI3K/AKT/
mTORc1 pathway. While circulating IGF-1 concentrations do not
determine RET-induced hypertrophy in humans [18], hypertro-
phy has now been shown to potentially occur through both PI3K-
AKT [19] and mTOR [20] independent pathways, even in pre-
clinical models. Perhaps the most convincing observation in favor
of a more divergent regulation of muscle growth, is the fact that
disparate exercise modes (e.g. RET vs. endurance exercise training
(EET)) can produce similar protein signaling patterns in humans
[21]. This suggests that the molecules, so far studied, are
pleiotropic and in our opinion probably important for any type
of tissue remodeling, regardless of the final physiological pheno-
type [22]. Therefore, a more innovative approach is needed to
define links between molecules and ensuing in vivo physiological
adaptations, than can be achieved with targeted western-based
molecular profiling.
Exercise training has also been postulated as a key tool to
reverse the impact of ageing on human skeletal muscle phenotypes
[23,24]. Yet, while some ‘genomic features’ of ageing have been
reported [25], we have noticed that the available global molecular
profiles of human muscle [23,24,26,27] do not identify consistent
molecular features. Furthermore, our recent work has highlighted
that physiological adaptations to exercise, whether that be
hypertrophy [28] or aerobic function [29], are highly heteroge-
neous in humans, implying that exercise may not be able to
‘‘reverse’’ muscle ageing [23] for some people. For example,
following .10-wk of supervised EET, ,20% of subjects show no
improvement in aerobic capacity while ,30% demonstrate no
improvement in insulin sensitivity [30,31]. Similarly, we reported
muscle hypertrophy ranging from 0.8 to 6.0 kg [28], while Raue et
al reported changes in muscle cross-sectional area (CSA) ranging
21.2 to +10.4 cm2 [24]. Both of these RET studies reported that
the outcome of supervised progressive RET did not relate to pre-
existing differences in characteristics (i.e., gender, age, pre-existing
muscle mass, physical activity levels or dietary habits) indicating
that there is not a simple explanation for the heterogeneity of the
gains in lean mass [28,32].
In recent years, we have focused on using the heterogeneous
responses to exercise training and OMIC techniques to uncover
molecular networks regulated by EET [33][29] or generate
molecular predictors of trainability [34], directly in humans. The
aim of the present work is to produce the first reproducible
molecular signature of human muscle age, and examine how such
a profile relates to new and established exercise adaptation gene
networks. We generated new gene-chip profiles from muscle
samples derived from two independent clinical cohorts, with a
continuous range of ages (18–79 y) and which originate from
distinct environments (UK and USA) and which were indepen-
dently processed in the laboratory. We also generated a new data
set of paired global RNA-responses to a supervised 20-wk RET
program (N=44), as well as utilizing various sets of published
acute-RET and chronic-EET gene-chips (total N= 200) data sets.
Finally, Ingenuity’s new IPA up-stream analysis tool [35] was used
to identify key features, within these novel age and exercise
signatures, to provide independent and robust molecular insight
into the heterogeneous nature of muscle hypertrophy, and human
muscle age.
Results
The paired differential analysis, comparing expression in 38
from 44 subjects before and after RET yielded a dataset of ,700
regulated genes (Dataset S1) and this gene-list related to a few
upstream regulators in IPA (Dataset S2). For logical reasons we
used only the 38 subjects that demonstrated a training effect [31].
This list included a 62-gene network (Figure 1A), representing the
transcriptional action of all-trans-retinoic acid (Tretinoin) and this
signature was highly ‘activated’ following 20-wk RET (Z-
score = 4.5 for directional consistency; P-value for transcript
overlap (p= 6610213)). In contrast, aryl hydrocarbon (AhR) and
V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)
signaling (Figure S1A) was inhibited, such that repression of
connected genes was removed, and thus target mRNAs up-
regulated.
We utilised the differential RNA response to 6-wks of EET [29]
to address the question of specificity of this RET molecular profile
to conditions of muscle growth. We have previously speculated
that a core set of gene-networks will be common to all types of
exercise and could represent basic determinants of tissue
adaptability [22]. Indeed, we found that several significant
upstream transcriptional regulators from the RET profile were
also significant significantly regulated by EET (Dataset S1) and the
majority of individual genes in the RET RNA signatures were
activated in an identical manner between RET and EET
(Figure 1B and Figure S1B). Thus while differential expression
in the Derby Resistance Exercise Training (DRET) study clearly
identifies a number of tissue remodeling related processes, these
are not specific to exercise training modality.
We then utilized the dataset from the Trappe laboratory
(GSE28422, ‘Study A’ from GEO). We removed the following
Author Summary
A fundamental challenge for modern medicine is to
generate new strategies to cope with the rising proportion
of older people within society, as unaddressed it will make
many health care systems financially unviable. Ageing
impacts both quality of life and longevity through reduced
musculoskeletal function. What is unknown in humans is
whether the decline with age, referred to as ‘‘sarcopenia,’’
represents a molecular ageing process or whether it is
primarily driven by alterations in lifestyle, e.g. reduced
physical activity and poor nutrition. Because the details of
such interactions will be uniquely human, we aimed to
produce the first reproducible global molecular profile of
human muscle age, one that could be validated across
independent clinical cohorts to ensure its general applica-
bility. We combined this analysis with extensive data on
the impact of exercise training on human muscle
phenotype to then identify the processes predominately
associated with age and not environment. We were able to
identify unique gene pathways associated with human
muscle growth and age and were able to conclude that
human muscle age-related molecular processes appear
distinct from the processes directly regulated by those of
physical activity.
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samples (or the related paired sample) because the following
samples appeared to have technical issues; GSM702424,
GSM702439, GSM702431, GSM702421, GSM702414,
GSM702436 and GSM702405 GSM702393, GSM702399,
GSM702411. Unfortunately we were declined access to the
phenotype data (individual muscle growth changes) for each
subject (Dr S Trappe, personal communication) and thus we were
unable to re-analyze their data to capture the growth related
responses, as their data-set included a number of ‘non-responders’
for lean mass gains. Nonetheless, we used the acute RE response
dataset found in the Trappe study (GSE28422) so that we could
explore the overlap between the acute RNA responses and chronic
RET adaptation. What we noted was that ,2% of the RNA
changes that occur with chronic adaptation in the DRET study,
were regulated in response to acute resistance exercise.
Molecular networks associated with muscle hypertrophy
Of greater physiological importance was our effort to identify
genes which link to the magnitude of muscle hypertrophy in
humans. Quantitative SAM analysis [3,36] identified 642 probe-
sets and interestingly the majority of genes identified were
negatively correlated with gains in lean mass (Dataset S2). The
probe-set list was imported into IPA (filtered at a 5% FDR) and
384 genes could be mapped to the IPA database for pathway
analysis. The enrichment score generated for the EIF2 canonical
pathway enrichment was extremely significant (P-val-
ue = 1610264) and the combination of these observations
indicates that the gene-list was both predictable (valid with
extensive literature) and statistically very robust (Figure S2). We
identified a number of regulators that could be responsible for
regulating the transcriptional signature that correlated to gain in
lean mass (Dataset S2).
Figure 2A presents the most striking finding, an active
rapamycin signature, equating to inhibition of mTOR signaling
[37]. This signature was comprised of genes that almost entirely
negatively correlated with lean-mass gain (Z-score = 2.8 for direc-
tional consistency; P-value for transcript overlap p= 1.4610230).
In short, subjects that demonstrated the largest gains in lean tissue
mass following 20-wks of RET have suppressed mTOR signaling
over the training period, a novel and controversial observation (all
raw data was manually checked for consistency of direction). A
second major transcriptional regulator was MYC, and the gene-list
driving its inclusion (Z-score 25.8 for directional consistency; p-
value for transcript overlap p= 4610243) overlapped with the
rapamycin network, equating to the inhibition of MYC activity.
MYC can be an upstream activator of mTOR signaling in cell
culture systems [38]. Thus these two robust observations are
consistent, and notably the signature evidence is based on entirely
independent data.
Close examination of the rapamycin associated gene network
(Figure 2A) reveals ,30 ribosomal RNA genes (a total of 70 genes
were in the lean mass gain associated list but not all featured in the
data-base of rapamycin regulated genes). The remaining genes
(Figure 2A) belonged to metabolic processes and other facets of
protein metabolism or signaling. To more easily appreciate the
characteristics of those subjects that were found to have the
greatest increase in lean tissue mass combined with a reduction in
ribosomal gene abundance, we plotted the quartile response in
Figure 1. Resistance exercise training induces an all-trans retinoic acid differential gene expression signature that is common with
endurance exercise training. A) Forty-four subjects completed a 20 wk supervised resistance exercise training program (RET) and biopsy RNA was
profiled before and 72 hr after training. Following SAM analysis of the 38 subjects that demonstrated a clear physiological gain, the gene list was
uploaded to the Ingenuity Pathway Analysis database (IPA) and the up-stream regulators were identified using IPA’s new up-stream tool. An All-trans-
retinoic acid (Tretinoin) gene expression literature network was found to have a significant overlap with the RET dataset (p = 6610213). Furthermore,
the direction changes of the common transcripts were sufficiently similar enough to conclude that ATRA like activity was increased (Z-score = 4.5). B)
We re-evaluated our earlier RNA responses to endurance exercise training (EET) study which involved biopsy profiles before and after 6 weeks
endurance training in 24 subjects [29], using the IPA tool and while the ATRA was not independently significant the vast majority of the genes within
the RET ATRA signature were regulated in an identical manner by EET.
doi:10.1371/journal.pgen.1003389.g001
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lean mass (Figure 2B). Baseline lean mass could not explain our
observation and in fact the four groups had the same mean age,
physiological characteristics, while the highest and lowest quartiles
for lean mass gain had exactly the same proportion of males and
females (Table 1). Figure 2C specifically illustrates a subset of the
ribosomal RNA genes, however all other rRNA genes were
consistent with this plot. There was an almost universal pattern of
down-regulation observed in high responders (shown in purple)
Figure 2. Inhibition of the mTOR-related expression network is correlated with gains in lean mass following RET. A) Quantitative SAM
analysis was used to relate the change in RNA expression in response to 10 wk RET in 44 subjects. The change in gene expression was related to the
change in lean mass (%) and a false discovery rate calculated based on permutation of the subject labels. Data were imported into IPA and 384 genes
(FDR,5%) could be mapped to the data-base for up-stream analysis. An active rapamycin signature, equating to inhibition of mTOR signaling was
discovered (Z-score = 2.8 for directional consistency; P-value for transcript overlap p= 1.4610230). B) Given the strength of the negative statistical
association between the rapamycin signature, we then plotted the data to establish the precise nature of the relationship. We presented the mean
gains in lean mass by quartiles establishing that 25% of the subject demonstrated negligible changes in lean mass. C) We selected a representative
subset of the genes from Figure 2A and plotted the mean changes with respect to lean mass changes. This established that those with the greatest
lean mass actually had a reduction in mTOR related genes with RET and not simple a lesser increase as one might have expected from first inspection
of Figure 2A.
doi:10.1371/journal.pgen.1003389.g002
Table 1. Baseline biochemical and physiological characteristics of the DRET cohort.
Phenotype Q1 (n=11) SE Q2 (n=11) SE Q3 (n=11) SE Q4 (n=11) SE
Basal upper lean leg mass 5550 6442 3284 6438 3595 6380 4689 6239
Change in lean mass (%) 0.5 60.2 2.4 60.1 4.0 60.3 9.4 62.1
Age (yr) 49.2 65.5 47.5 64.6 53.1 65.7 51.1 65.7
Male: female ratio 8:3 - 4:6 - 4:6 - 8:3 -
Pre-training BMI 25.5 60.9 25.9 60.6 25.9 60.8 26.6 61.2
Pre-training fasting Insulin 3.6 60.7 5.0 60.6 5.0 61.0 4.2 60.6
Pre-training fasting Glucose
(mmol/l)
5.4 60.2 5.7 60.1 5.5 60.3 5.7 60.2
Type I fibres 34.8 60.7 32.9 60.8 31.4 60.7 31.7 61.1
Type IIA fibres 31.0 60.6 32.0 60.6 34.1 60.6 33.3 60.8
Type IIX fibres 33.9 60.8 34.7 61.0 33.8 60.7 34.9 61.1
Leg strength (Newtons) 2270 6264 2206 6265 2073 6166 2149 6124
doi:10.1371/journal.pgen.1003389.t001
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while subjects that were unable to increase muscle mass (shown in
blue) substantially up-regulated these genes, as would be expected
from the qSAM statistical analysis (FDR,5%) in Figure 1A.
Thus, our analysis strategy enabled the discovery of an entirely
novel in vivo feature of the mTOR growth pathway, while standard
differential RNA expression analysis (pre vs. post sample) could
not. We also plotted the relationship between physiological
characteristics, protein-phosphorylation during acute net anabolic
situations (resistance exercise coupled with feeding) with lean mass
gain in these subjects using principal component analysis (PCA).
Selected variables were scaled and principal components 1 and 2
are presented. In Figure 3A, it is abundantly clear that none of the
metabolic or physiological characteristics shared variance with the
main component capturing lean mass gain variation following
RET. Likewise, while protein kinase abundance or protein kinase
activation status varied in a manner consistent with the literature,
none of these acute net anabolic responses were correlated to gains
in RET induced lean mass or shared variance with gains in lean
mass when studied prior to 20-wk RET (Figure 3B). In short, only
the unbiased transcriptomics method was able to identify a
biological profile distinguishing between high and low responders
for lean mass gain.
Age muscle gene networks
Identification of the determinants of skeletal muscle mass has
obvious implications for treating age-related sarcopenia. There is
no longitudinal molecular analysis of ageing muscle in humans.
However using cross-sectional gene-chip data-sets, attempts have
been made to identify age-related gene expression changes. For
example, Melov et al., reported that differences in gene expression
between a cohort of young and old subjects can be removed
through a RET program [23]. RET removed some aspect of the
‘inactivity’ related component of the difference between young and
old subjects but when we contrasted their age-signature with other
publically available muscle age datasets [23,24,26,27] no overlap
was apparent.
To investigate this issue further, we utilised the Melov et al., data
and the data from Trappe and our lab. We used SAM analysis to
compare young with old subjects in each study. For the Trappe
study we had 13 young (20–30 y) and 11 old subjects (.80 y). We
used baseline samples from DRET, 10 young (20–29 y) versus 16
old subjects (64–75 y), and finally we re-analysed the Melov et al.,
data [23] which had 26 younger (18–28 y) and 25 older subjects
(65–85 y). As can be clearly observed in Figure 4 there was no
overlap between the three studies indicating that a reproducible set
of ‘ageing’ genes cannot be generated with this statistical or
experimental approach. Our re-analysis of the GO analysis (using
DAVID) of earlier studies [26,39], using the appropriate back-
ground files [40], also confirmed that mitochondrial RNA changes
in ageing cannot be claimed as being a reproducible hallmark of
ageing, despite the presumed association with inactivity. Re-
analysis of the Melov et al., data did identify a mitochondrial gene
expression signature (less significant than the original analysis due
to comparison with a more appropriate ontological background)
but in that study the older subjects were substantially de-trained
and aerobic function was not presented. This gene-set is also
known to reflect physical activity [29] and inactivity in humans
[41] and thus it shouldn’t be attributed to age per se anyway. To
consolidate the conclusion that there was no common finding
across these three studies, we entered the individual gene-lists in a
gene ontology analysis to evaluate if some common pathways were
enriched in each list, even if the member genes differed. Only 1
Figure 3. Using principal component analysis to evaluate the relationship between physiological and acute protein signaling
events to RET induced gains in lean mass. A) Change in lean mass following 20 wk RET and a number of physiological parameters which
demonstrated the most variance were scaled to a common value and plotted using principal component analysis in R. Principal component (PC) 1
captured the major variance in lean mass gains across subjects however none of the commonly postulated physiological parameters varied with lean
mass (linear regression analysis demonstrated no significant association also). PC2, the second largest proportion of independent variance also
demonstrated no association between factors such as fiber type or age and gains in lean mass. B) Phospho-protein signaling 2 hr after a combined
exercise and nutrition acute intervention (to promote anabolic signaling) were scaled and plotted with change in lean mass following 20 wk RET.
Again these acute signaling events shared little common variance in either PC1 or PC2 with changes in lean mass with 20 wk RET.
doi:10.1371/journal.pgen.1003389.g003
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ontological group was common to 2 from the 3-gene lists and it
related to mitochondrial processes indicating that even when the
older subjects have a lower physical capacity a decline in
mitochondrial genes is not always a prominent feature of age-
related changes.
Therefore, an alternative approach to identify age-related gene
expression profiles in human muscle was required. To achieve this
we utilised QSAM, which we have previously applied and
validated to some extent for human studies [3]. We applied
QSAM to generate a list of muscle transcript levels, which
correlated with subject age (20–75 yr), with correction for multiple
testing. This allowed us to identify genes that either negatively or
positively associated with the subject age. This has not been
attempted before because previous studies did not have a
sufficiently wide and continuous range of ages to generate such
data [23,24,26,39]. However, such an analysis would be of limited
value if some of the observations could not be independently
reproduced, using a distinct set of clinical samples. To this end, we
generated 52 new U133+2 profiles (17–63 yr) from muscle biopsy
samples from the HERITAGE Family Study [42] and were able to
identify a set of 580 genes or transcripts (Dataset 3) which were
correlated with age in both clinical studies and which was enriched
in post-transcriptional and chronic disease traits (Figure S3) but
not mitochondrial related gene-sets.
We found in IPA that the age-related dataset was consistent
with the activation of the PGR (z-score = 2.6 and P-value = 0.001)
and RXR (z-score = 2.0 and p-value = 0.0001) proteins and 5-
fluorouracil agonism (Z-score = 2.2 and P-value = 0.0005,
Figure 5A). Each mediator orchestrated a set of either positive
(yellow) or negatively (green) age-correlated genes such that both
overlap and direction were similar to the literature-constructed
networks. Critically, these networks were not significantly related
to the lean-mass associated gene-list (Figure 5B) or differentially
regulated by either acute RE (Figure S4A) or chronic endurance
exercise (Figure S4B). Thus it is unlikely that these new age-related
observations reflect simple confounding factors, such as exercise
training or being physically active.
There was also inhibition of certain protein mediators with age
(Figure 6A) including c-MYC (z-score =22.8 and p-
value,0.0001) and CLDN7 (z-score =22.6 and p-value = 0.05).
Again, no clear relationship with acute exercise or endurance
training was apparent (Figure S5), while a closer association
with genes related to gains in lean mass was noted (Figure 6B)
with some key exceptions. Notably inhibition of MYC was
predicted in both the lean-mass and age-related gene lists (with
gene-correlations in the same direction) which we would not
expect if muscle ageing was simply the ‘opposite’ of muscle
growth or lack of response to exercise training. Furthermore,
large differences in gene expression still existed when comparing
the age groups and the pre and post-training samples in the
Trappe dataset (data not shown). The age-related expression
signature was also related to RNA signatures in the Broad
Connectivity database, including multiple serotonin antagonists
and appears opposite to DNA topoisomerase inhibition (Dataset
S4). Finally, we examined whether the age-related genes were
over represented at genomic loci using Positional enrichment
analysis [43]. Both Chromosome 1 (q12) and 13 (q21.33) had
significant hits and the genes associated with those locations can
be found in Figure 7A and 7B and the remaining analysis in
Dataset S5.
Figure 4. Differential gene expression analysis, contrasting young and old subjects, does not produce a reliable biomarker
signature of age. Several attempts have been to define a set of genes that differ in skeletal muscle between young and old human subjects. We re-
analysed three of the most robust and largest human studies with common methods, including our new study, and contrasted the genes identified
to be differentially regulated using SAM analysis and Gene Ontology analysis. No common pattern of differential gene expression could be found
using this analysis method indicating that no prior gene signature for muscle ageing can be considered a reliable marker of muscle age in humans.
Gene ontology analysis found that both the Trappe and Melov data sets had modest enrichment in mitochondrial genes, which were down-regulated
with age however this was not true for the DRET study and both Melov and Trappe data-sets had elderly with much lower physical fitness levels
making it impossible to attribute these changes to age per se with differential expression analysis.
doi:10.1371/journal.pgen.1003389.g004
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Discussion
We have carried out unbiased molecular analyses on both new
and pre-existing human muscle data-sets (acute and chronic
exercise, RET or EET and ageing) from which we have been able
to define: (i) a ‘generic’ set of molecular networks that are activated
irrespective of exercise-training mode in humans, i.e., RET or
EET, (ii) the differential effects of acute exercise versus chronic
exercise training on molecular networks, (iii) the molecular
networks that are specifically modulated in relation to the extent
of human muscle hypertrophy, and (iv) the first reproducible set of
age-related transcriptional changes further supporting our view
that large human sample sizes, using unbiased molecular profiling
techniques [4,29,44] is an important strategy for translational
medical science.
Exercise mode and the specificity of the molecular
response
Muscle hypertrophy is the most recognized adaptation to RET.
However, there are numerous other adaptations that occur, to
support the biochemical, physical and metabolic requirements of a
growing muscle. For example, hypertrophy is associated with
activation of muscle satellite cells to support growth [45] while
RET stimulates angiogenesis proportional to muscle fiber growth
(rather than increasing capillary-to-muscle fiber area as EET [46]).
Furthermore, along with accretion of contractile proteins, the
extracellular matrix (ECM) undergoes substantial remodeling after
RET [47]. Clearly then, successful hypertrophy is the summation of
complex intra/extra-muscular cross talk to co-ordinate hypertrophy.
As such, we believe that teasing out the molecular networks
regulating adaptation in vivo requires charting the relationship
between the modulation of molecular factors with that of the
physiological outcome(s) [29].
Our initial analysis revealed that activation of a Tretionin (all-
trans retinoic acid (ATRA)) and inactivation of aryl hydrocarbon
receptor (AhR) are common molecular responses to training,
irrespective of exercise mode i.e., RET or EET. ATRA is the
active form of vitamin A, which serves as a ligand for two families
of widely expressed nuclear receptors; the retinoic acid receptors
(RAR) that bind to ATRA and the retinoid X receptors (RXR)
that bind to its stereoisomer, alitretionin (9-cis-RA). Although little
work exists on ATRA signalling in skeletal muscle, Halevy et al.
showed exogenous ATRA promoted myogenic cell differentiation
[48] which is allied to the function of ATRA amongst various cell
types [49]. Given the post-mitotic properties of myonuclei, this may
point to a novel link between ATRA-like signalling and aspects of in
vivo satellite cell activities induced by exercise training. In support of
this idea, we also observed IGF-1 and IGF-2 up-regulation in both
RET and EET, and this is thought to play a role in satellite cell
activation and differentiation [50,51][52]. ATRA-like signalling has
also been shown to modulate endothelial cell maturation and
angiogenesis in tube formation assays [53] suggesting a role for
activation of this network in exercise-induced angiogenesis, while
angiogenic factors are also associated with satellite cell activation
and differentiation [54]. Indeed, we identified up-regulation of
homeobox (HOX) genes (e.g. HOXB3/7), which have roles in
vascular remodelling and angiogenesis [55]. Thus this collection of
genes is likely contributing to vascular remodelling-induced both by
Figure 5. Quantitative SAM analysis using a continuum of age versus gene expression produces network hubs that are activated
with human muscle age. Using a total of 97 U133+2 Affymetrix gene-chips newly produced from two independent studies, the DRET study and
the HERITAGE family study we produced a novel analysis that relied on the full age-range present in these data sets. A) We first found a set of genes
that co-varied with age in the DRET study and then confirmed that 580 of these were also related to age in the HERITAGE study. Mitochondrial genes
were not a feature of this linear age vs gene analysis. We then mapped the Affymetrix probe-sets to the IPA database and examined the up-stream
analysis output. We found in IPA that the age-related dataset was consistent with the activation of the PGR (z-score = 2.6 and p-value= 0.001) and
RXR (z-score = 2.0 and p-value= 0.0001) proteins and 5-fluorouracil agonism (Z-score = 2.2 and p-value= 0.0005). B) We noted that some members of
these age-related networks were also associated with lean mass gains in humans. However about 50% of the common genes were positively
associated with lean mass gain and age; and 50% were regulated in a discordant manner. Clearly some responses can be causal, some may be purely
correlative and some may represent compensatory events.
doi:10.1371/journal.pgen.1003389.g005
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Figure 6. Quantitative SAM analysis using a continuum of age versus gene expression produces network hubs that are inhibited
with human muscle age. Using a total of 97 U133+2 Affymetrix gene-chips newly produced from two independent studies, the DRET study and
the HERITAGE family study we produced a novel analysis that relied on the full age-range present in these data sets. A) We first found a set of genes
that co-varied with age in the DRET study and then confirmed that 580 of these were also related to age in the HERITAGE study. Mitochondrial genes
were not a feature of this linear age vs gene analysis. We then mapped the Affymetrix probe-sets to the IPA database and examined the up-stream
analysis output. We found in IPA that the age-related dataset was consistent with including c-MYC (z-score =22.8 and p-value,0.0001) and CLDN7
(z-score =22.6 and p-value= 0.05). B) A few members of these age-related networks were also associated with lean mass gains in humans and this
included mTOR regulated genes, which were negatively associated with increasing age and thus in contrast to the lean-mass association.
doi:10.1371/journal.pgen.1003389.g006
Figure 7. Positional enrichment analysis identified age-related genes that were over-represented on 4 chromosomes including
Chromosome 1 and 13. A plot of selected genes found to be over-represented at 1q12 and 13q21. A) Positional enrichment analysis identified 3
genes at each loci and B) the relationship with age of each gene was plotted with the linear correlation coefficient provided and the FDR derived
from the qSAM analysis (FDR,5%). Genes at these loci included proteins that are known to influence mTOR related signalling.
doi:10.1371/journal.pgen.1003389.g007
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RET [56] and EET [57]. In addition, the turnover of ECM
components is activated when smooth muscle cells are exposed to
exogenous ATRA, thereby suggesting this pathway is involved in
ECM remodelling [58]. Indeed, the (activated) ATRA gene list was
highly enriched in collagen genes. Finally, while one cannot rule out
that the degree of modulation of ECM (which differed between
RET and EET) may influence aerobic adaptation [29,31] it would
appear to be a constituent feature of muscle growth and remodelling
per se.
The AhR is a ligand-activated transcription factor known to
mediate the negative effects of environmental xenobiotic contam-
inants such as dioxin (i.e., TCDD; 2,3,7,8-tetrachlorodibenzo-[p]-
dioxin). This receptor belongs to the basic-helix-loop-helix
(bHLH)/PAS (Period [Per]-AhR nuclear translocator [Arnt]-
Single minded [Sim]) family of heterodimeric transcriptional
regulators [59]. There have been a number of studies in which
physiological clues have been gathered as to the function of AhR.
For example, AhR has shown tumour suppressor effects i.e., when
receptor levels are down-regulated by siRNA [60] the G1/S
transition of the cell cycle and cell proliferation is promoted,
suggesting a growth inhibitory role of the receptor. There also
exists links between AhR and angiogenesis. Vascular endothelial
growth factor (VEGF), a major growth factor that regulates
angiogenesis is transcriptionally regulated by hypoxia-inducible
factor-1 alpha (HIF-1a) in response to tissue hypoxia and muscle
contraction [61]. Hypoxia stabilizes HIF-1a, which forms
heterodimers with HIF-1b, also known as the AhR nuclear
translocator (ARNT). ARNT can heterodimerize with AhR,
minimizing the ability of ARNT to interact with stabilized HIF-
1 to induce VEGF production. Finally, matrix remodelling is
negatively affected during AhR activation. For example, AhR
activation blocks regenerative processes during zebra fish caudal
fin regeneration while impairing expression of genes involved in
the structure and remodelling of the ECM [62]. Thus, inactivation
of AhR-signalling may facilitate ECM and vascular remodelling
occurring in response to both RET and EET (Figure 1).
The notion that both ATRA and AhR pathways are potent
regulators of cell growth, differentiation, ECM remodelling,
vascularization, organogenesis and embryogenesis [63] underlines
their key roles in tissue development and homeostasis. Moreover,
since adaptation to RET and EET both involve aspects of cellular
remodelling, muscle satellite cell activities [64], ECM and vascular
remodelling, we suggest that ATRA and AhR molecular programs
are playing a previously undefined but central role in regulating
‘‘generic’’ features of exercise adaptation [22]. Finally, since
ATRA and AhR gene networks that were regulated during long-
term exercise training (Figure 1), were not reflective of those
modulated in the hours after a single bout of exercise [24,33], this
casts doubt over ascribing formative purpose of acute exercise gene
networks, which more likely represent stress pathways instigated
by unfamiliar activities or simply the acute energy crisis in
exercised muscle (in agreement with the lack of a striking ontology
profile). This may explain why acute mRNA changes do not
overlap with the chronic exercise patterns or, in our hands, relate
to the networks that associate with the degree of gain in lean mass
(see below).
Networks activated in a manner directly related to
muscle growth
Following the identification of what might be called generic
‘adaptability’ [22] molecular networks, we were interested to see if
we could identify any molecular networks that were regulated in
proportion to the degree of muscle hypertrophy in individual
subjects. The justification for this approach was based on the
marked heterogeneity in capacity for muscle growth in humans,
with gains ranging from 0% to 22% [24,28,65]. In the DRET
study, we found a similar range of changes in muscle size (23% to
+28%) and the analyses of the gain-related gene networks yielded
striking results. We first discovered that there existed a correlation
between capacity for human muscle lean mass gains and activity of
both c-MYC and mTORc1 sensitive genes, including a large
group of ribosomal RNA (rRNA) genes (,70/560 total rRNAs).
We further demonstrated that the nature of the association was not
as one would be expecting from pre-clinical research, but rather
there was a reduction in rRNA gene expression when greater
muscle hypertrophy was observed (Figure 2B).
We speculate that human high-responders to hypertrophy
potentially show superior efficiency in protein synthesis (i.e.,
protein yielded per RNA) and/or a reduction in proteolytic
responses to RET. Nonetheless, it should also be noted that while
rRNA expression negatively correlated to gain in lean mass, the
highest responders tended to have higher levels of rRNA pre-
training for individual rRNAs and hence the absolute abundance
was similar post-training. This pattern of response clearly
demonstrates that ‘more’ mTOR activation (e.g. more rRNA
production) in humans is neither a hallmark nor a necessity for gains
in lean mass in vivo. Our observations in humans also contrast with
the molecular responses observed during acute synergist ablation
induced hypertrophy [66], raising further doubts over the
relevance of such pre-clinical models to inform about physiological
muscle growth in humans. Regardless, our data demonstrate that
high-responders for muscle hypertrophy evoke an ‘‘anti-growth’’
transcriptional response during a period of successful muscle
growth with more studies being required in high or low lean-mass
responders to investigate this phenomenon unambiguously.
While the unbiased transcriptional profiling yielded novel
insights into human muscle growth responses, we also attempted
to link training responsiveness to subject baseline physiology and
the acute response of phospho-protein (AKT-mTORc1) signaling
in response to an anabolic stimulus (RET combined with optimal
nutrition [67]). We used correlation analysis to examine the
relationship between key factors that have been speculated to be
important for human muscle growth (e.g. body composition, fiber-
type, metabolic and signaling molecule status). We found no
significant shared variance between any of these variables and
gains in lean mass, as presented in Figure 3 using PCA. We
utilized PCA for visualizing the integration of physiological and
molecular data because it enables an over-view in a single plot of
how physiological and molecular aspects may vary within the
major ‘units’ of variance of a particular dataset rather than plotting
multiple individual scatter plots. By doing this, it becomes easier to
visualize when paired relationships are behaving as expected, such
as total protein and phospho-protein positions within each
principal component. Unusual patterns could be used to identify
problem areas such as when detection methods (e.g. antibodies)
are poorly functioning.
As can be seen in Figure 3A, while principal component 1 was
dominated by the variation in lean mass gains, basal lean mass, fat
mass or fasting glucose did not vary. These data are in agreement
with previous studies in which baseline physiological status was
unable to select out high-responder status to hypertrophy [28]. We
integrated the acute changes in phospho-protein signaling under
the conditions of RET plus nutrition as an index of growth
signaling potential in each subject. This seemed a valid approach
as muscle hypertrophy is the product of nutrition and exercise-
induced muscle protein synthesis [68]. While pre-training acute
‘‘anabolic’’ signals did not share variance with gains in muscle lean
mass (Figure 3A), some weak relationships appeared between
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acute ‘‘anabolic’’ signaling elements following exposure to RET
(Figure 3B) and gains in lean mass. Collectively, this underlines
that while acute changes in phosphorylation may associate with
those of acute remodeling processes (i.e., muscle protein synthesis
responses) they are a poor indicator of future leans mass gains.
Previously we have found a degree of dissociation between AKT-
mTOR signals [69,70] and muscle protein synthesis, while others
have shown that acute synthesis does not, but some signaling
molecules do, relate to future gains in lean mass [71]. We contend
that using these individual signals as acute proxies for RET muscle
growth is not going to be the most sensitive strategy.
Age-associated and exercise-associated molecular
networks
There is a long established relationship between canonical
pathways related to muscle growth and mechanisms that are
associated with extended life-span in model organisms [72]. For
example, inhibitors of mTORc1 and PI3K (a gene also known as
‘‘age-1’’) activity can extend life-span in Caenorhabditis elegans,
drosophila and mice [72]. As the number of people living beyond
their eighth decade rises, it is expected that skeletal muscle atrophy
and dysfunction (sarcopenia and dynapenia respectively) will
become an increasing public health challenge [73]. Activation of
mTORc1 and muscle IGF-1 signalling is associated with muscle
cell growth experimentally while chronic inhibition of mTOR has
been predicted to induce muscle frailty in humans [14,74].
Likewise, reduced S6K1 (ribosomal protein S6 kinase) activity of
the multifaceted regulator of cell growth would be thought to
impair the retention of muscle mass in humans [75]. Thus there is
a clear molecular basis to believe that processes under-pinning
ageing, longevity, sarcopenia and muscle growth will be strongly
inter-connected.
We found a list of ,500 genes which track with age in human
muscle across two independent cohorts, when our analyses utilised
a continuum of ages. This contrasts with the irreproducibility of
previous RNA versus muscle age datasets. Using this data we then
evaluated which age-related gene networks link to muscle growth
signalling or a variety of exercise scenarios [24,29,56,76]. The
motivation for this is that these factors cannot be independently
controlled for in human studies and thus post hoc considerations are
essential. The first clear observation was that the reproducible age-
related gene-list and the lean-mass gain related gene-list both had
inhibition of MYC as a key transcriptional feature immediately
indicating that age and muscle growth are not exact opposites.
Further, the key upstream regulators of the age-related gene list
(e.g. PGR, RXR, Claudin7) contained a set of genes which were
largely unrelated to the RET and EET transcriptomes, or the
acute exercise responses [24,76] for that matter. Claudin-7 activity
was inhibited with age (Figure 6) and appears to relate to
developmental differentiation and is strongly regulated by
androgen signaling and HGF in vitro [77]. According to the IPA
publication database the RXR ligand, CD437, induces a
transcriptional signature that is consistent with age-related gene
correlations, involving a network that is for 2/3rd negatively
correlated with increasing age and for 1/3rd positively associated
with age (i.e. with age KLF5 and IRS2 expression increases). Note
that the ATRA signature, characteristic of increased physical
activity in our hands, should operate through the RAR pathway.
However, there is some overlap in the down-stream gene
activation and thus both age-related changes and exercise activate
some common features related to Vitamin A biology. In short, it is
abundantly clear that the age-related changes in gene expression
are not simply the ‘opposite’ [23] of the profiles seen with exercise
or exercise training.
Positional enrichment analysis [43] was used to map the ,500
age-related genes to chromosomal localisation, as attempts to link
DNA variants with ageing have so far been only partly successful
suggesting that an alternative approach may provide useful
insights. We found several loci that yielded a significant
enrichment score with ,1q12 (e.g. PDE4DIP) and ,13q21 (e.g.
LMO7 (FBXO20)) yielding the most significant scores (Figure 7).
PDE4DIP is a binding partner of phosphodiesterase 4D (PDE4D)
which partners with Rheb to be a cAMP-specific negative
regulator of mTORc1 [78]. When PDE4D binds Rheb it inhibits
the ability of Rheb to activate mTORC1 and hence it is plausible
that PDE4DIP (also called myomegalin) impacts on this relation-
ship, as an increased interaction between Rheb and mTOR
should promote growth. On chromosome 13, another growth and
differentiation gene, Lmo7, was identified. Lmo7 impacts on
myoblast differentiation, being required to induce Pax3 and
MyoD expression [79]. Lmo7 is positively associated with age in
muscle, while we have previously identified PAX3 as an up-stream
transcriptional regulator of the EET induced transcriptome [29],
highlighting further why the age-related transcriptome is not
simply the opposite of exercise training. i.e., muscle ageing is not
simply inactivity and thus is unlikely to be reversed by only activity
(this does not at all contest that muscle function can be
substantially retained by physical training in many but not all
subjects).
Perspectives and limitations
Over the past 2 decades, therapeutic advances for complex
chronic diseases have failed to generate all the progress predicted
by the emergence of genetic technologies [80]. Part of the reason
for this is that the investment in forward genetic pre-clinical
models [81] has not yielded the expected validation of drug targets
and it is now widely accepted that the clinical approach to chronic-
disease management will have to reflect on numerous interactions
between environmental and molecular factors [82]. Thus, an
alternative approach, whereby identification of disease networks
directly observed in clinical populations may have merit and lead
to a more rapid translation of basic science [3,4,34,40,83].
Validation of such observations is dependent on access to sets of
independent clinical data sufficiently large to have robust statistical
power and diverse enough to be able to generalize the conclusions.
It is safe to say that our approach is not at all universally favoured,
as there is still a great reliance on so-called ‘validation’ studies
involving forward and reverse genetic strategies in mice and cells.
We suspect that such validation studies will, in the end prove to be
context dependent and no easier to interpret than our in vivo
molecular studies.
The singular advantage of our approach is that our data is
generated under the precise conditions that would ultimately
require therapeutic intervention. However, in the present analysis
we focus on components of dynamic function, namely muscle
mass, as the study of muscle performance will require determina-
tion of a wider range of muscle functional parameters (power,
torque, velocity) and larger clinical studies, studies which do not
exist at present. We also appreciate that our current observations
would benefit greatly from follow-on genetic association studies in
humans and by pharmacological or nutritional intervention
studies. For example we have shown that a simple relationship
between more mTOR activation and muscle growth does not exist
in vivo in humans, albeit we are relying in part on the
pharmacological activity of rapamycin to support this observation
(off target effects may be present) and do not yet have kinetic data
to understand the dynamic nature of this new relationship. We
also failed to find a link between inter-subject variation in acute
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phospho-protein anabolic signalling and gains in lean mass. This
may reflect the choice of time-point that we profiled the protein
responses under. However, it must also be recognised that
quantification of protein abundance changes suffers from numer-
ous complications, including compression or exaggeration of
dynamic range and challenges with specificity. Time will tell if our
systems-biology translational medicine approach [84] exceeds the
performance of traditional approaches taken to yield new
therapeutic advances for human health.
Materials and Methods
This manuscript relies on several microarray studies to produce
and independently validate molecular associations. We present a
new 89-chip analysis (44 paired samples and 1 baseline-only
sample) combined with direct comparisons to literature-based
microarray data [23,24]. The Trappe Lab chip data (GSE28422)
was processed using identical methods to our new clinical data.
Our QC analysis identified a number of chips that should be
removed prior to statistical analysis. Inclusion of such data can
both increase or decrease detection of differential gene expression
(derived from technical and not biological variation). The analysis
as a whole represents the most comprehensive examination of
human molecular exercise-ageing pathways, and the application of
independent chip resources provides a gold-standard level of
validation.
Derby RET (DRET) subject characteristics
Subjects were recruited from an age range of 18 to 75 y. Before
beginning the study all subjects were screened using a medical
questionnaire, physical examination and resting ECG with
exclusions for overt muscle wasting (.2 SD below age norms)
[85], metabolic, respiratory/cardiovascular disorders or other
major contraindications to a healthy status. All subjects had
normal blood chemistry and were normotensive (BP,140/90). All
subjects performed routine activities of daily living and recreation
but did not participate in moderate to high intensity aerobic
exercise and none had participated in RET in the last 24 months.
Body composition was measured at screening and following RET
by dual energy X-ray absorptiometry (DEXA) (Lunar Prodigy II,
GE Medical Systems). Subject positioning on the DEXA bed was
optimized to allow the region of interest (ROI) body compart-
ments to be analyzed separately. The upper leg ROI was selected
as the area inferior to the lowest visible point of the coccyx to the
mid-point of the patella. All subjects gave their written, informed
consent to participate after all procedures and risks were
explained. This study was approved by the University of
Nottingham Medical School Ethics Committee and complied
with the Declaration of Helsinki. The clinical data from these
subjects were first reported in 2012 [56]. For the purposes of this
article a total of 45 from the original 51 subjects were utilised as
this represents the total number of gene-chip profiles that passed
the appropriate quality control processes (N= 89 U133+2
Affymetrix chips).
DRET protocol
The 20-wk fully supervised RET programme was designed to
achieve skeletal muscle hypertrophy. Subjects trained three times
per week, with each session lasting approximately 60 min. During
four weeks of induction training (to ensure adoption and
adherence to correct technique) intensity was increased from
40% to 60% 1-RM. For the remaining 16-wk of training intensity
was set at 70% 1-RM with multiple sets of 12 repetitions, with two
min rest between sets. 1-repetition maximum (1-RM) assessments
were made every four weeks to ensure that the intensity of loading
was constant. Subjects were excluded from the study for non-
compliance, defined as: non-attendance for.6 consecutive sessions,
less than 75% attendance, or failure to complete the set exercise
regime on .15% attendance. Muscle biopsies (,150 mg) were
taken under fasted-non-exercised (‘‘basal’’) and optimal growth
conditions (acute exercise-fed conditions, 2.5 h after a single bout of
exercise) both before and after chronic-RET from the vastus lateralis
muscle under local anaesthesia (2% lidocaine, with the use of a
conchotome biopsy forceps, as previously described [56]). Blood
was collected in pre-chilled tubes containing Lithium Heparin,
plasma was separated by centrifugation and was then stored at
280uC until analyses. Plasma glucose concentration was measured
on a clinical chemistry glucose analyser (ILAB 300 Plus). For insulin,
blood was collected in pre-chilled tubes containing EDTA, plasma
was separated by centrifugation within 30 min of collection and was
then stored at 280uC until final analyses. Plasma insulin
concentration was determined using high sensitivity insulin ELISA
systems (Immunodiagnostic systems limited).
Immuno-blotting
Muscle biopsies (,20 mg) were homogenized in ice-cold
extraction buffer (10 mL.mg21) containing 50 mM Tris-HCl
(pH 7.4), 0.1% Triton X-100, 1 mM EDTA, 1 mM EGTA,
50 mM NaF, 0.5 mM activated sodium orthovanadate (Sigma
Aldrich, Poole, UK) and a complete protease inhibitor cocktail
tablet (Roche, West Sussex, UK). Homogenates were centrifuged
at 10,000 g for 10 min at 4uC. Bradford assays were used to
determine supernatant protein concentrations after which samples
were standardized to 1 mg.mL21 in Laemmli loading buffer.
Samples were heated at 95uC for 5 min before 15 mg of protein/
lane was loaded on to Criterion XT Bis-Tris 12% SDS-PAGE gels
(Bio-Rad, Hemel Hempstead, UK) for electrophoresis at 200 V
for ,60 min. Gels were equilibrated in transfer buffer (25 mM
Tris, 192 mM glycine, 10% methanol) for 30 min before proteins
were electro-blotted on to 0.2 mm PVDF membranes (Bio-Rad) at
100 V for 30 min. After blocking with 5% low-fat milk in TBS-T
(Tris-Buffered Saline and 0.1% Tween-20; both Sigma-Aldrich,
Poole, UK) for 1 h, membranes were rotated overnight with
primary antibody (all AbCam, Cambridge, UK) against our target
proteins (AKT, mTOR, p70S6K1, 4EBP1, eEF2) at a concentra-
tion of 1:2000 at 4uC. Membranes were washed (365 min) with
TBS-T and incubated for 1 h at room temperature with HRP-
conjugated anti-rabbit secondary antibody (New England Biolabs,
UK), before further washing (365 min) with TBS-T and
incubation for 5 min with ECL (Immunstar; Bio-Rad). Blots were
imaged and quantified by assessing peak density, after ensuring
bands were within the linear range of detection using the
Chemidoc XRS system (Bio-Rad, Hemel Hempstead, UK).
Protein phosphorylation was corrected for loading to actin loading
control before the protein signals were subject to PCA to explore
relationships between ‘anabolic signals’, specifically in terms of
muscle hypertrophy responsiveness.
RNA extraction and chip processing
Total RNA was isolated from muscle biopsies taken before and
after (72 h after the final training session) RET by chloroform-
phenol based extraction. In brief, paired tissue samples (obtained
before and after RET) of ,20 mg each were processed
simultaneously in 1 mL TRIzol (Invitrogen) using a Mini-
Beadbeater-8 (Biospec Inc.) for 15 sec on the ‘‘homogenize’’
setting. After 5 min of incubation at room temperature, 200 mL of
chloroform (Sigma-Aldrich) was added and samples shaken
vigorously by hand. Samples were briefly incubated on ice prior
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to centrifugation at 12,000 g for 15 min. The supernatant was
removed and mixed with isopropanol (Sigma-Aldrich) and spun
once more at 12,000 g for 10 min, after 10 min of incubation.
After a single washing step with 75% EtOH RNA pellets were re-
suspended in 40 mL DEPC-treated water (Ambion) and quantified
using a NanoDrop Spectrophotometer (NanoDrop Technologies).
RNA purity was assessed using the A260/A280, A260/A230 ratios
and stored at 280uC. Samples were put through this process in
pairs (pre-post samples) while the order of subject processing was
carried out to distribute ‘non-responders’ equally.
Reverse transcription of RNA was carried out using the
Affymetrix 39 IVT express kit. 100 ng of total RNA was reverse
transcribed as per manufacturer’s protocol, and quantified using a
Nanodrop ND-1000 instrument. aRNA was fragmented and
labeled as per manufacturers protocol and hybridized to Affyme-
trix U133+2 arrays (Affymetrix, USA). Arrays were washed,
stained and scanned following Affymetrix standard procedures,
using an Affymetrix 3000 7G scanner and Affymetrix 450 wash
station. A visual inspection of each array was carried out.
Microarray analysis and bioinformatic procedures
Low-level processing of all arrays was undertaken using
Bioconductor in R. The Affy package was used to carry out
MAS5 based normalization and generate present, marginal and
absent (PA) scores. NUSE plots were generated and combined
with PCA, outlier samples were identified where both the NUSE
plot and PCA was supportive of its exclusion (,2% of arrays). For
baseline correlation analysis, all samples that passed QC were
utilized (N= 45). This procedure was applied to the data-set
originating from the Trappe laboratory (GSE28422, [24]) and
outliers removed from the dataset that failed the QC process,
leaving n= 96 for analysis. Pre-exercise training muscle biopsy
samples from the HERITAGE family study (N= 50) were also
analyzed to yield a second independent data set with a continuous
span of age-ranges (see below). The Trappe and HERITAGE
datasets therefore represent independent datasets which we
utilized, where possible, to validate the pathway analysis of our
study. Such confirmation benchmarks results using thousands of
data-points and is more desirable that targeted real-time qPCR
confirmation (where the gene selection is biased and the sample
size inappropriate to make statistical conclusions). Annotation of
all CEL files used ‘hgu133plus2cdf_2.9.1.tgz’ while annotation of
probe-set lists was then updated using the Ingenuity Pathway
Analysis database, as of August 2012.
Our first objective was to identify the gene-networks regulated
in proportion to gains in upper leg muscle mass (hypertrophy), the
same location as our biopsy sample. Such analysis relies on the
established principal that adaptation responses (for the majority of
phenotypes) to exercise training in outbred populations is highly
variable, typically reflecting genetic and epigenetic variation and
in genomic variation. We utilized quantitative SAM analysis [3,36]
to generate a list of genes which vary in a positive and negative
manner with changes in DEXA assessed upper leg lean mass. This
was applied to PA filtered data and the statistical parameter
generated is a q-value (false discovery rate). This provided for the
first time a candidate list of gene-changes that may exhibit primary
or secondary influence over muscle growth in humans. The gene-
list was then subject to IPA based pathway analysis and in
particular the Upstream Analysis tool in IPA was utilized. This
analysis has similarities to the Molecular Connectivity Database
[86] where pre-existing collections of RNA signatures are
compared with our lean-mass related gene list, and significant
overlaps identified. An overlap P-value is generated based on the
degree of overlap between the gene-set within the IPA database
(which reflects the RNA molecules changed in response to a
‘mediator’ such as a transcription factor or a drug) and our data
set, adjusting for data set sizes using the Fischer’s Exact Test. We
accepted a stringent P-value of p,0.001 as being significant. A
second parameter is the activation ‘‘z-score’’ where the directional
change in RNA is compared between the IPA mediator data-set
and our lean-mass gain gene list. The z-score informs on whether
the drug/protein mediator is likely to be ‘active’ or ‘inhibited’
during gains in lean mass. Thus, if we discovered that an antagonist
is ‘inhibited’ in our analysis, this indicates that the drug target is
activated. However, in the present study the data-input refers to
genes, which positively or negatively correlate with lean mass gains
e.g. if we find a ‘‘Statin’’ signature was inhibited, it is interpreted
that HMG-CoA reductase regulated genes are negatively corre-
lated with lean mass gain.
The two-step process presented above generates a focused gene-list
with a high statistical rigor for true positive associations. This type of
analysis also utilizes the full range of physiological response observed,
however it assumes that expression of important genes will relate in a
linear manner to lean mass gain and thus can not discover all
appropriate associations. We then contextualize the statistical findings
both in terms of subject characteristics and through comparison of the
response of these significant networks with independent gene-array
data (e.g. [24]). At this stage we utilized descriptive statistics, plotting
the significant network genes as simple expression values relative to
the quartile distribution of lean-mass gains to allow for clear
discussion of the results. As these plots are based on the z-scores
and P-values as above, no further statistical analysis is presented.
Following identification of our primary objectives we then
carried out a classic differential expression analysis using SAM.
Given that we have established that chronic differential expression
patterns, following exercise training, are dependent on the
presence of physiological adaptation we removed 6 subjects that
demonstrated no gain in lean mass. This yielded a list of
differentially expressed genes that could then be compared with
the RET gene-list generated from the Trappe laboratory data and
our published exercise studies [24]. Secondary analysis, where
subject age or baseline lean-mass was related to baseline gene-
expression was carried out using quantitative SAM analysis as
described above [3,36]. This allowed us to present comparisons of
the RET gene-list with other modes of exercise, such as endurance
exercise training or disease [3,29] and age-related analysis [23,24].
PCA was utilized to visualize the association between selected
physiological and protein expression parameters and training
induced changes in muscle lean mass. PCA was implemented in R,
using prcomp() command, which calculated a singular value
decomposition and plots the selected principal components using
the plot command in R. All data was individually transformed to a
median value within that data set so that all variables were within
a consistent data range. In each case the majority (,65%) of the
total variance was captured by the first two principal components.
Finally, positional gene enrichment analysis (PGE) was used to
identify whether the classification genes (or the classifier network
genes) were significantly enriched within given chromosomal
regions [43]. This analysis is based on the following rules: Rule 1:
it contains at least two genes of interest, Rule 2: there is no smaller
region containing the same genes of interest, Rule 3: there is no
bigger region with more genes of interest and the same genes not
of interest, Rule 4: there is no larger encompassing region with a
higher percentage of genes of interest, Rule 5: there is no smaller
encompassed region with a better P-value, Rule 6: it does not
contain any region having less than expected genes of interest. The
approach of PGE exhaustively evaluates the over-representation at
all chromosomal resolution levels simultaneously.
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Supporting Information
Dataset S1 Exercise regulated genes from multiple studies.
(XLSX)
Dataset S2 Genes regulated in proportion to lean mass gains in
DRET.
(XLSX)
Dataset S3 Genes that co-vary with human age across DRET
and HERITAGE.
(XLSX)
Dataset S4 Results from the connectivity map analysis for drugs
that regulate age-related genes.
(XLSX)
Dataset S5 Chromosomal localization analysis.
(XLSX)
Figure S1 Gene networks activated through inhibition of a
repressor molecule AHR or KRAS following 20 wk RET A)
KRAS Z=22.8 p= 3.88E-04 and AHR Z=22.4 p= 2.96E-07
B) 6 wk of EET KRAS Z=22.5 p= 1.92E-11 and Z=22.9
p= 9.66E-14.
(TIF)
Figure S2 Canonical pathways associated with lean muscle mass
gains derived from IPA database.
(TIF)
Figure S3 Canonical pathways associated with age derived from
IPA database.
(TIF)
Figure S4 Gene networks positively associated with age in
human muscle contain RNA’s which are not regulated by either A)
acute resistance ET (Trappe data-set GSE28422) nor B) 6 wk
endurance exercise training (Keller et al 2011 JAP).
(TIF)
Figure S5 Age related gene networks where the central node is
inhibited with age contain RNA’s which are positively correlated
with age and increased with A) acute resistance ET (Trappe data-
set GSE28422) and B) 6 wk endurance exercise training (Keller et
al 2011 JAP) providing a clear indication that age and exercise are
not simple ‘opposites’ at the molecular level.
(TIF)
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